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The pharmacological properties of essential oils have been widely studied. However the interaction and contribution of the individual
constituents assayed singularly and in combination remains relatively unexplored. To investigate these possible interactions, various essential oil
constituents (EOC's) were combined and the interactions on their antimalarial and toxicity properties determined using the tritiated hypoxanthine
incorporation and the tetrazolium-based cellular viability assays, respectively. In combination, two inactive EOC's (IC50 values greater than
1 mM), ρ-cymene and carvacrol interacted in a synergistic manner (∑FIC=0.02) against a chloroquine-resistant strain of Plasmodium falciparum.
This interaction was comparable to that between the potent E- and Z-(±)-nerolidol (IC50 value: 0.9±0.3 μM) and the standard antimalarial,
quinine (IC50 value: 0.13±0.04 μM) (∑FIC=0.01). However, this latter combination also potentiated the toxicity (∑FIC=0.001) of each
molecule. A similar increase in toxicity was noted between ρ-cymene and γ-terpinene, as well as E- and Z-(±)-nerolidol and (−)-pulegone. These
results show that the pharmacological activities of individual EOC's can vary greatly when used in combination, and show potential as adjuvants
in the elimination of malaria infections.
© 2010 SAAB. Published by Elsevier B.V. All rights reserved.
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If medical science has to only rely on monotherapy alone to
eradicate disease, it would implicate a serious catastrophe to human
health as parasitic resistance is increasing at an unprecedented rate
(Cassella et al., 2002; Cox et al., 2001). To counteract this increase
in resistance, combination therapy has been implemented to ensure
successful treatment of malaria infections. In South Africa, the
current antimalarials used in combination therapy include
lumefantrine with artemether and quinine with either doxycycline
or clindamycin (South African Department of Health, 2009).
However, another concern is the possibility of increased
cytotoxicity following the addition of two agents which may⁎ Corresponding author. Tel.: +27 11 7172271; fax: +27 11 6435415, +27
865534725.
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doi:10.1016/j.sajb.2010.08.002interact with each other. Similarly, the cytotoxicity of an essential
oil may be changed by the presence of other compounds, where the
compounds may potentiate each other's activity or complex
together to enhance overall toxicity or alter their respective
bioavailability such that their therapeutic range is exceeded. The
interaction between two or more molecules is said to be synergistic
if the potency of the combination is higher than the expected
activity of the individual molecule. However, if the potency of the
combination is lower, then the end result is defined as an
antagonistic interaction (Bell, 2005).
It has been claimed that the most dominating constituents in
the essential oil are those eliciting the activity attributed to the
whole oil (Nakatsu et al., 2000). Despite this fact, constituents in
low concentrations are often found to be as effective as the
principal constituent (Cassella et al., 2002; Kaur et al., 2009;
Nakatsu et al., 2000). Moreover, synergistic and antagonistic
effects could also be achieved by using the essential oils in
combination, but also by combining the essential oils with otherts reserved.
Table 1
The combined interaction between two essential oil constituents or an essential
oil constituent and control drug on the in vitro growth of P. falciparum and
human kidney epithelial cells.
EOC1 EOC2/control drug ∑FIC value Interaction
Antimalarial interactions
p-Cymene (−)-Pulegone 11.30 Antagonistic
E- and Z-(±)-Nerolidol (−)-Pulegone 2.03 Antagonistic
Linalyl acetate (+)-α-Pinene 0.91 Additive
p-Cymene γ-Terpinene 0.37 Synergistic
(+)-α-Pinene Carvacrol 0.22 Synergistic
Linalyl acetate Carvacrol 0.14 Synergistic
E- and Z-(±)-Nerolidol p-Cymene 0.09 Synergistic
Carvacrol p-Cymene 0.02 Synergistic
E- and Z-(±)-Nerolidol Quinine 0.01 Synergistic
Toxicity interactions
p-Cymene (−)-Pulegone 0.306 Synergistic
E- and Z-(±)-Nerolidol (−)-Pulegone 0.076 Synergistic
p-Cymene γ-Terpinene 0.002 Synergistic
E- and Z-(±)-Nerolidol Quinine 0.001 Synergistic
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published studies investigating such interactions (Cassella et al.,
2002; Kamatou et al., 2008a; Su et al., 2008; Van Vuuren and
Viljoen, 2009b; Van Vuuren et al., 2009a). Studies on these
interactions are vital, since essential oils have great potential as
adjuvants in the symptomatic management or treatment of a wide
range of health problems (Cowan, 1996; De Smet, 1997). Several
studies have shown the antimalarial activity of essential oils
isolated from plants such as Cochlospermum (Benoit-Vical et al.,
1999),Helichrysum (VanVuuren et al., 2006),Lippia (Valentin et
al., 1995), Salvia (Kamatou et al., 2005), Tetradenia (Campbell et
al., 1997) and Virola (Lopes et al., 1999).
Although these studies have determined the composition and
biological activity of the essential oil, there has been little or no
work done with regards to which of the major and/or minor
constituents are responsible for the inhibitory activity of the
malaria parasite. Since the essential oil is composed of
numerous EOC's, it is likely that an interaction will exist
between two or more of the EOC's. To examine this possibility,
selected EOC's with varying activity profiles were combined
and their antimalarial and toxicity properties recorded.
2. Materials and methods
2.1. Essential oil constituents
Selected essential oil constituents were purchased from
Sigma-Aldrich and the purity and percentage composition
verified to the supplier's specifications by gas chromatography
(minimum purity≥95%).
2.2. Antimalarial activity
A chloroquine-resistant strain of Plasmodium falciparum
(FCR-3) was continuously maintained in vitro according to the
method of Jensen and Trager (1976) and Van Zyl et al. (2006)
and synchronised using the 5% (w/v) D-sorbitol methodology
as described by Lambros and Vanderberg (1979). To determine
the effects of the EOC's on parasite growth, the basic method of
tritiated hypoxanthine uptake assay according to Desjardins
et al. (1979) was modified and used to accommodate testing of
select EOC's in combination. These combinations were
repeated in triplicate to confirm consistency. Based on the
antimalarial activity of the individual EOC's, eight combina-
tions were selected as seen in Table 1, and one of the most
active EOC was combined with quinine. In this assay a parasite
suspension consisting predominantly of the ring stage, was
adjusted to 0.5% parasitaemia and 1% haematocrit and plated
out with various combined ratios and concentrations of the two
test compounds for 24 h. Six fixed ratios of the two EOC's or
EOC and quinine were prepared such that as the concentration
of the EOC increased, the concentration of the other EOC/
quinine decreased. The concentrations chosen for the ratios
were based on the concentration of the individual EOC or
quinine required to inhibit 50% parasite growth (IC50 value).
Positive controls containing only one compound were also
prepared. From each of the fixed ratios, a further six 1 in 10dilutions were prepared such as to determine the IC50 value. All
assays were carried out using untreated parasites and uninfected
red blood cells as controls. After 24 h, labelled 3H-hypoxan-
thine was added and 24 h thereafter the 3H-DNA harvested on
glass fibre filter paper with a Titertek® cell harvester. The IC50
value was determined for each ratio from the log sigmoid dose
response curve generated by the Enzfitter® software.
2.3. MTT toxicity assay
The transformed human kidney epithelial (Graham) cells
were continuously maintained in vitro at 37 °C in 5% CO2
according to the method of Mosmann (1983) and Van Zyl et al.
(2006). The MTT [3-[4,5-dimethyl-2-thiazol-2yl]-2,5-diphenyl-
2H-tetrazolium bromide]-microculture cellular viability assay
was used to determine the interaction of the EOC's/controls on
the growth of human cells. The trypsinized cell suspension was
adjusted and 0.5 million cells/mL plated out with the two
EOC's/controls as described for the antimalarial combination
assay. After 44 h of incubation, 20.1 mM MTT (USB) was
added to the plates and incubated for a further 4 h. Dimethyl
sulfoxide (DMSO) was added to stop the reaction and dissolve
the formazan crystals. The absorbance was read at the test
wavelength of 540 nm and reference wavelength of 690 nm and
the percentage cellular viability calculated with the appropriate
controls taken into account. The concentration that inhibited
50% of cellular growth (IC50 value) was determined for each
ratio from the log sigmoid dose response curve generated by the
Enzfitter® software.
2.4. Data analysis
The IC50 values of each ratio was determined and the type of
interaction determined in two ways, namely an isobologram and
determination of the sum fractional inhibitory concentration
(ΣFIC) value for all ratios and individual EOC's/controls. The
data points for construction of the isobolograms were obtained
664 R.L. Van Zyl et al. / South African Journal of Botany 76 (2010) 662–667for the various ratios by plotting the IC5012 in combination/
IC501 alone (on the X-axis) versus the IC5012 in combination/
IC502 alone (on the Y-axis). Values on the isobologram lying
above the line were interpreted as being antagonistic, below as
synergistic and those on or near the line as additive. It must be
noted that there may be some points on the isobolograms
overlying each other and sometimes cannot be clearly seen.
Secondly, to verify the interaction read from the isobologram,
the ∑FIC of the two selected EOC's (1 and 2) used in the
combination was calculated for each combination according the
following equation:
∑FIC ¼ IC5012 in combination
IC501alone
+
IC5012 in combination
IC502alone
Values from these ∑FIC calculations were interpreted as
follows: b0.5 as synergistic, 0.5–1.0 as additive, N1.0 as
indifferent, while that N2.0 as antagonistic (Bell, 2005). Each
combination was done in triplicate to confirm consistency.0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5
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Fig. 1. The combined effect of essential oil constituents on the in vitro3. Results and discussion
3.1. Antimalarial activity of the combined essential oil constituents
Essential oils have widely been reported to possess in vitro
and in vivo antimalarial activity at relatively low concentrations
(Kamatou et al., 2008b; Lopes et al., 1999; Tchoumbougnang
et al., 2005; Van Zyl et al., 2006). However, the activity of the
individual and combined effect of the EOC's has not been
extensively investigated.
When two EOC's were combined and assessed for their
antiplasmodial activity the overall interaction between the
various combinations were found to be synergistic, although to
varying degrees (Table 1; Fig. 1B). The combination between the
least active and most active EOC's, namely, p-cymene (1528.8±
44.9 μM) andE- and Z-(±)-nerolidol (0.9±0.3 μM) (Van Zyl et al.,
2006) displayed a pronounced synergistic interaction (Fig. 1B). E-
and Z-(±)-Nerolidol with its reported mechanism of action of
interfering with isoprenoid biosynthesis (Goulart et al., 2004)
potentiated the antimalarial activity of p-cymene which had0.00 0.25 0.50 0.75 1.00 1.25
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Z-(±)-nerolidol might assist p-cymene to reach the site of action in
the parasites, or they may have acted on the complementary targets
(Aqil et al., 2007).
This latter synergistic interaction could account for the good
antimalarial activity of the volatile oils from Virola surinamensis,
which predominantly consisted of p-cymene (42.0%), with
smaller amounts ofα-pinene (11.7%),β-pinene (5.2%), nerolidol
(3.8%) and γ-terpinene (1.0%) (Lopes et al., 1999). It was
reported that 100 μg/ml of this oil and nerolidol inhibited 100%
development of the young trophozoites to schizont stage without
haemozoin formation over 48 h of treatment. The promising
antimalarial activity of this oil could also have been due to the
potent synergistic interaction between p-cymene with nerolidol
and/or γ-terpinene (1006.7±18.7 μM) (Table 1). Whereas
nerolidol and α-pinene (1.2±0.2 μM) have shown to possess
potent antimalarial activity, p-cymene, γ-terpinene and β-pinene
(318.5±35.6 μM) probably did not significantly contribute to the
overall effect when working individually (Van Zyl et al., 2006).
This illustrates the importance of considering the combined effect
of EOC's, even though the active constituents only represent
15.5% of the essential oil.
Two antagonistic interactions were observed, namely
between (−)-pulegone with E- and Z-(±)-nerolidol or p-cymene
(Table 1; Fig. 1A). In contrast, when two active EOC's [linalyl
acetate (1.4±0.1 μM) and (+)-α-pinene] were combined, an
additive interaction was observed (Table 1). It may be proposed
that the antagonistic interactions are due to competition of the
two EOC's when partitioning into the red blood cell or parasitic
membranes (Turina et al., 2006) or accumulating at the same
site and thereby interfering with each other's inhibitory effects.
This has been described for mefloquine and chloroquine, where
mefloquine inhibits the ability of chloroquine to cause an
accumulation of undigested haemoglobin in the parasitic food
vacuole (Famin and Ginsburg, 2002). Alternatively, the two
EOC's could compete with each other and thereby neutralise their
respective parasitocidal effect. The combination of artemisinin
with iron chelators has been shown to interact antagonistically;
presumably due to the chelators binding ironwhich is essential for
the formation of C-centred radicals that are formed by the
interaction of the endoperoxide bridge in artemisinin and iron
(Krishna et al., 2006).
Moreover, this study shows thatwhen twoEOC's are combined,
variable interactions exist depending on the concentration and ratio
of the agents used. Boyom et al. (2003) stated that in the case of
malaria, the physical properties of essential oil constituents namely
its low density (~0.94 g/ml) and lipophilicitywhich facilitates rapid
diffusion across cell membranes, might enhance targeting of the
active components into the intracellular malaria parasite. However,
the final interaction between the two EOC's depends on their
respective cellular targets.
3.2. Cytotoxic profile of the essential oil constituents
The combined effects of various EOC's were assessed for their
resultant toxic properties (Table 1; Fig. 1C, D). Essential oils
consist of numerous constituents present in variable concentra-tions. Thus, to examine the interaction between some of these
EOC's various combinations were assessed to determine how
they may contribute to the overall toxicity profile of the essential
oil. All tested EOC combinations potentiated each other's toxicity
profile (Table 1). For example, the toxicity IC50 values of the
individual EOC's, such as E- and Z-(±)-nerolidol and p-cymene
were 5.5±1.2 μM and 673.6±35.4 μM respectively; but when
combined the IC50 values decreased dramatically by more than
10 fold. Similarly, for the other combined EOC's, the combined
toxic effect was more potent compared to the effects of the
individual EOC's (Table 1).
Thus, although the linear alcohol, E- and Z-(±)-nerolidol and
the monocyclic ketone, (−)-pulegone displayed very promising
antimalarial activity when used individually (Van Zyl et al.,
2006); their antagonistic interaction voided any potential of
their combined administration (Table 1; Fig. 1A). These initial
results indicate that they are not ideal candidates to be used in
combination therapy due to the increased toxicity profile of the
two EOC's when used in combinations (Fig. 1C; Table 1).
Thus when comparing the two latter combinations it would
appear as if EOC's should not be combined for therapeutic
application. However, when used individually they have proven
to be effective in increasing the transdermal permeation of drugs
such as cardiovascular (propranolol, nicorandil) and cancer drugs
(tamoxifen, 5-fluoruracil) (Aqil et al., 2007; Krishnaiah et al.,
2005).When tested in animal or human studies, the application of
terpenes resulted in variable adverse effects depending on the
route of administration. But if applied topically the reaction
ranged from little to no skin irritation to eczema and dermatitis
depending on the dose and duration of application (Aqil et al.,
2007; Bakkali et al., 2008; Pisseri et al., 2008; RIFM, 2008). It has
been reported that cytotoxicity is associated more often with
phenols, aldehydes and alcohols (Bakkali et al., 2008).
The combination of twomonoterpenes, namely γ-terpinene and
p-cymene (Fig. 1D) also displayed increased toxicity towards the
human kidney epithelial cells (∑FIC=0.002). Likewise when the
ketone, (−)-pulegone was combined with p-cymene (Fig. 1D), the
combination had a more toxic profile (∑FIC=0.306) (Table 1).
Thus, based on these observations of the in vitro effect of the EOC's
on human kidney epithelial cells, the route of administration and the
concentration used should be carefully monitored to avoid
detrimental and even fatal adverse effects. These cytotoxic effects
in the kidney could be due to a membrane or a membrane–protein
interaction, since monoterpenes are known to penetrate and
partition in the monomolecular layers of dipalmitoyl-phosphati-
dylcholine in cellular membranes (Lawrence, 2000; Turina et al.,
2006).
3.3. The combined antimalarial and cytotoxic effects of quinine
and E- and Z-(±)-nerolidol
The combination of a classical antimalarial drug, namely
quinine with E- and Z-(±)-nerolidol displayed a synergistic
interaction (∑FIC value=0.01), but had a high toxicity profile
(∑FIC=0.001) (Table 1). The ability of these two agents to
target separate cellular components may have contributed to
their enhanced interaction; with E- and Z-(±)-nerolidol
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isoprenylation of proteins, resulting in the interference with
mitochondrial metabolic processes like pyrimidine biosynthesis
(De Macedo et al., 2002; Goulart et al., 2004). In contrast,
quinine is reported to inhibit haemozoin formation and to
decrease plasmodial DNA strand separation and transcription,
thereby inhibiting protein synthesis (Warhurst, 2001; Noedl
et al., 2003). Thus, if a patient were to be admitted with a
malaria infection and had been taking traditional aromatic
phytomedicines for his fever and chills, the treatment of the
patient would not be compromised if quinine were to be
administered. In addition, nerolidol has been reported to
increase the transdermal permeability of hydrophilic drugs
(e.g. quinine) through biological membranes, providing an
alternative route of administration (Aqil et al., 2007).
In the absence of an effective vaccine against malaria, people
rely on chemotherapeutic agents to prevent and treat an
infection (Craig et al., 2009). These results indicate that plant-
derived or chemically synthesised EOC's have the potential to
be used in adjunct therapy with antimalarial agents. In addition,
they could be used as new templates for drug design.
In many chemotherapeutic regimens, drugs are used in
combination to delay or overcome factors of resistance. If
EOC's were to be combined with a standard antimalarial agent,
such as quinine, the combined antimalarial effect would be
potentiated (∑FIC=0.01). However, so would the likelihood of
increased adverse effects (∑FIC=0.001; Table 1). Thus, the
interaction in an in vivo system needs to be evaluated to
determine if the adverse effects would outweigh the therapeutic
efficacy of this combination.
It is clear that further research needs to be conducted to
determine the toxic profiles of the whole essential oils, the
individual EOC's and combinations with other essential oils or
“western” drugs. In addition, it is known that the essential oil may
exert a severe effect on an individual organism or cell type, but
maybe inert to other cell types. Thus, it is essential that the in vivo
effects be determined, taking into account the metabolism of the
individual molecules and the resultant metabolites which could
alter the inhibitory properties observed in this study.
From the results obtained, an inference can be drawn that
some EOC's are not ideal candidates to form an integral part of
the combination therapy, due to their increased toxicity profiles.
Although the two more active compounds tested displayed
potent antimalarial activity; in combination, E- and Z-(±)-
nerolidol with (−)-pulegone or quinine displayed high toxicity
to the test cell line. Although this does indicate some
cytotoxicity to mammalian cells, the complete profile and
metabolism of these terpenes need to be investigated. It can be
concluded that in combination some EOC's potentiate each
others' mechanisms of action which may contribute to the
management and treatment of microorganisms resistant to
standard drugs and warrants further investigation.
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